Wen-Kuan Huang

14PUBLICATIONS
28CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Forensic epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 28, 2025
The first reported case of effective targeted therapy in extrahepatic cholangiocarcinoma harboring an epidermal growth factor receptor exon 19 deletion.

Ling-Jen Hung, Shih-Chiang Huang, Chih-Wei Wang

|Nov 20, 2024
Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancer.

Wen-Kuan Huang, Yan-Jei Tang, Chiao-En Wu

|Sep 26, 2023
Cancer Therapy-Related Cardiac Dysfunction in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy.

Dong-Yi Chen, Cheng-Hung Lee, Ming-Lung Tsai

|Jan 18, 2023
Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report.

Wen-Kuan Huang, Shih-Chiang Huang, Chien-Ming Chen

|Nov 08, 2022
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.

Hung-Kai Chen, Po-Jung Su, Yan-Lin Wang

|Aug 17, 2022
Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges.

Wen-Kuan Huang, Chiao-En Wu, Shang-Yu Wang

Pageof 3

Frequent Collaborators

5 joint publications

Chiao-En Wu

3 joint publications

Jen-Shi Chen

3 joint publications

Chun-Nan Yeh

2 joint publications

Yi-Ru Pan